DNAJC5G

Across TCGA pan-cancer cohorts, DNAJC5G Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DNAJC5G data layer compared with 23 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher DNAJC5G Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated DNAJC5G expression acts as an unfavorable survival marker.

HNSC, KIRP, and UCEC are the cancer types where DNAJC5G Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	III,IV	0.148	0.680	.012	12	view →
KIRP	DFS	Median	All	0.181	0.768	.004	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SKCM	OS	Median	All	0.257	0.781	.019	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

DNAJC5G–HNSC (DFS)

Open the HNSC breakdown →